Get startedLog in
    Picture of Kezar Life Sciences logo

    KZR — Kezar Life Sciences News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMicro CapNeutral
    All News

    Brief: Kezar Life Sciences To Present Complete Results From The Phase 2 Mission Trial Of Zetomipzomib In Patients With Lupus Nephritis

    Picture of Kezar Life Sciences logoKezar Life Sciences
    14/10/2022 12:02
    Oct 14 (Reuters) - Kezar Life Sciences Inc  KZR.O :
    * KEZAR LIFE SCIENCES TO PRESENT COMPLETE RESULTS FROM THE
PHASE 2
MISSION TRIAL OF ZETOMIPZOMIB IN PATIENTS WITH LUPUS NEPHRITIS
AT THE AMERICAN SOCIETY OF NEPHROLOGY’S KIDNEY WEEK 2022 ANNUAL
MEETING

Source text for Eikon:  ID:nBw83dVyVa 
Further company coverage:  KZR.O

    Recent news on Kezar Life Sciences

    See all news